HNRNPA3P1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.66522351463527E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.06149591525696E-11 |
Normal-vs-Stage2 |
4.816200E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
7.535900E-03 |
Stage1-vs-Stage2 |
5.564000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.527000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.162000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.41404723672667E-12 |
Normal-vs-AfricanAmerican |
4.05519999802095E-08 |
Normal-vs-Asian |
8.405900E-02 |
Caucasian-vs-AfricanAmerican |
9.773600E-01 |
Caucasian-vs-Asian |
6.195600E-01 |
AfricanAmerican-vs-Asian |
7.317200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.03079999997014E-06 |
Normal-vs-Female |
6.00369998160488E-09 |
Male-vs-Female |
7.944400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.787500E-04 |
Normal-vs-Extreme_Weight |
3.4755000000164E-07 |
Normal-vs-Obese |
5.758700E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.940000E-01 |
Normal_Weight-vs-Obese |
3.543800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.572200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.733410E-01 |
Normal-vs-Age(41-60Yrs) |
1.55211999999239E-05 |
Normal-vs-Age(61-80Yrs) |
2.08249999467114E-08 |
Normal-vs-Age(81-100Yrs) |
3.927600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.827400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.950000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.176400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.607230E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.862400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.136000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.773600E-01 |
Normal-vs-Grade 3 |
8.857000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.204000E-01 |
Grade 2-vs-Grade 4 |
7.773600E-01 |
Grade 3-vs-Grade 4 |
8.857000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.30646621193864E-12 |
Normal-vs-N1 |
7.440100E-03 |
N0-vs-N1 |
6.139200E-03 |
|
|